Weight Watchers launches a fully integrated digital platform offering comprehensive support for members using GLP-1 medications, featuring personalized nutrition, coaching, and community. Discover the future of weight management.
Experts warn injectable weight-loss drugs such as Ozempic are reducing consumer appetites, posing a significant challenge to the fast-food sector's traditional business model in Canada.
Discover Tanice, the Toronto Sun's latest SUNshine Girl - a model and entrepreneur balancing garden maintenance with fitness passions. Learn her inspiring story today!
Novo Nordisk's experimental obesity drug amycretin demonstrates significant weight loss results in mid-stage study, advancing to late-phase testing for diabetes patients.
Danish pharmaceutical giant Novo Nordisk faces major setback as Alzheimer's drug trials fail. Learn how this impacts the weight-loss leader's expansion plans.
Eli Lilly becomes the first pharmaceutical company to achieve a US$1 trillion market valuation, driven by unprecedented demand for its weight-loss treatments. Discover how this milestone reshapes the industry.
Country superstar Jelly Roll reveals dramatic new look after shaving beard for first time in decade following 200-pound natural weight loss transformation.
Two million Canadians using GLP-1 drugs like Ozempic are dramatically changing food consumption patterns, removing $3.3 billion annually from Canada's food economy. Learn how this trend affects groceries, restaurants and agriculture.
Meghan Trainor reveals how negative comments about her weight loss inspired her new single 'Still Don't Care.' The singer opens up about her health journey and body image struggles.
Novo Nordisk introduces $349 cash price for Wegovy weight-loss drug ahead of schedule. Learn how this affects Canadian healthcare access and affordability.
Actress Sydney Sweeney discusses her dramatic 35-pound weight gain to portray boxer Christy Martin in a new biopic, while also addressing recent controversies.
Discover why some patients experience hair loss while taking GLP-1 medications like Ozempic. Learn about the science behind this side effect and expert recommendations.
Supreme Court refuses appeal for Quebec man accused of $1.8 million weight-loss fraud. Extradition to U.S. proceeds in international scam case. Read the full details.
Discover the truth about 'Ozempic penis' - the viral claim about GLP-1 medications. Urologists explain why it's an optical illusion and reveal real sexual side effects.
Celebrity chef Gordon Ramsay refuses to create menus for diners on weight-loss drugs like Ozempic, sparking debate. Discover his controversial stance and its potential impact.
Pfizer triumphs in dramatic $10 billion bidding war for obesity drug maker Metsera, securing crucial White House-backed deal to compete in weight-loss market. Read the full story.
Former President Donald Trump unveils ambitious strategy to dramatically reduce costs of groundbreaking weight-loss medications, promising relief for millions struggling with obesity.
Former President Donald Trump reveals groundbreaking agreement with pharmaceutical giant to make obesity drugs more affordable and accessible across the United States.
Major pharmaceutical giants Novo Nordisk and Eli Lilly experience significant stock surges as former President Donald Trump considers a groundbreaking obesity drug partnership, potentially revolutionizing weight loss treatment accessibility.
Pharmaceutical giant Eli Lilly reports explosive growth driven by Mounjaro and Zepbound, creating intense investor competition and reshaping the obesity treatment landscape.
Pharmaceutical giants and startups race to develop next-generation weight-loss treatments as demand soars and market valuations skyrocket in this healthcare revolution.
New Canadian research exposes the limitations of BMI, revealing millions with normal weight may have 'hidden obesity' and face serious health risks. Discover the silent epidemic your scale isn't showing you.